Table 2.
The treatment costs for 12 months in the different groups (USD/kg/y).
| Item | Stepwise group n = 86 | TPO-RA group (monotherapy) n = 12 | TPO-RA group (combination therapies) n = 18 |
|---|---|---|---|
| Cost of medicines, median (range) | 0.05 (0.01-1399.25) | 395.11 (88.81-1233.44) | 357.04 (90.40-1090.65) |
| Cost of rescue therapies, median (range) | 17.07 (0-136.45) | 0 (0-34.11) | 17.05 (0-68.27) |
| Total cost, median (range) | 68.26 (0.01-1415.30) | 395.11 (100.88-1267.57) | 373.85 (107.39-1106.94) |
Due to the loss of follow-up, the treatment cost data at 12 months included 86 cases in the stepwise group and 18 cases in the TPO-RA group (combination therapy).
TPO-RA, thrombopoietin receptor agonist.